{"id":"https://openalex.org/W2061618384","doi":"https://doi.org/10.1016/j.ygyno.2011.12.052","title":"Phase II study of intravenous bevacizumab (bev) and paclitaxel (pac), and intraperitoneal (ip) cisplatin (c), followed by bevacizumab (bev) maintenance, for advanced ovarian cancer: A report on progression-free survival (PFS) and toxicity","display_name":"Phase II study of intravenous bevacizumab (bev) and paclitaxel (pac), and intraperitoneal (ip) cisplatin (c), followed by bevacizumab (bev) maintenance, for advanced ovarian cancer: A report on progression-free survival (PFS) and toxicity","publication_year":2012,"publication_date":"2012-03-01","ids":{"openalex":"https://openalex.org/W2061618384","doi":"https://doi.org/10.1016/j.ygyno.2011.12.052","mag":"2061618384"},"language":"en","primary_location":{"id":"doi:10.1016/j.ygyno.2011.12.052","doi":"https://doi.org/10.1016/j.ygyno.2011.12.052","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2011.12.052","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110235410","display_name":"LaToya Perry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Perry","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021715275","display_name":"Grainger S. Lanneau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Lanneau","raw_affiliation_strings":["CDR MC USN, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CDR MC USN, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111784025","display_name":"J. Curiel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Curiel","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001069897","display_name":"Cara Amanda Mathews","orcid":"https://orcid.org/0000-0001-8461-4568","observed_orcids":["https://orcid.org/0000-0001-8461-4568"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Mathews","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004006667","display_name":"Katherine Marie Moxley","orcid":"https://orcid.org/0000-0003-1903-5126","observed_orcids":["https://orcid.org/0000-0003-1903-5126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Moxley","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102768256","display_name":"Lisa Michelle Landrum","orcid":"https://orcid.org/0000-0002-4010-6833","observed_orcids":["https://orcid.org/0000-0002-4010-6833"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Landrum","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069337573","display_name":"Kathleen N. Moore","orcid":"https://orcid.org/0000-0002-5803-0718","observed_orcids":["https://orcid.org/0000-0002-5803-0718"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Moore","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053990407","display_name":"Joan L. Walker","orcid":"https://orcid.org/0000-0002-5034-4309","observed_orcids":["https://orcid.org/0000-0002-5034-4309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Walker","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061736280","display_name":"Robert S. Mannel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Mannel","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108555243","display_name":"Donald Scott McMeekin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. McMeekin","raw_affiliation_strings":["University of Oklahoma, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma, Oklahoma City, OK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.14466626,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"125","issue":null,"first_page":"S22","last_page":"S22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9079999923706055},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8949999809265137},{"id":"https://openalex.org/keywords/intraperitoneal-chemotherapy","display_name":"intraperitoneal chemotherapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/advanced-ovarian-cancer","display_name":"advanced ovarian cancer","score":0.9369999766349792},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.6850000023841858},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9900000095367432},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9345797300338745},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.920792818069458},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7574560642242432},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7444751262664795},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7311806678771973},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6664773225784302},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6555229425430298},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5164880752563477},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4855961203575134},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4846063554286957},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.411052942276001},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32846570014953613}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ygyno.2011.12.052","doi":"https://doi.org/10.1016/j.ygyno.2011.12.052","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2011.12.052","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2263037777","https://openalex.org/W2225002082","https://openalex.org/W2508779196","https://openalex.org/W4237324201","https://openalex.org/W2107402595","https://openalex.org/W2937594202","https://openalex.org/W2416520496","https://openalex.org/W2551530648","https://openalex.org/W4403084447","https://openalex.org/W4360608361"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}